CXCL10 and neoplasm: The results revealed that αPD-L1scFv-hFc immunotherapy stimulated and activated T lymphocytes in CT26-derived BALB/c immunotherapy-sensitive model that may be the “hot tumor” characteristic with higher T cell population and tumor-intrinsic IFNs and CXCL10 expression.